. Flow cytometric analysis of CTLA expression on CD4 and CD8 T cells in spleen. Tumor free mice, CRTL (untreated and only CaCl2 treated mice), PEF -PEF2 treated mice, PEF+Ca-PEF2 and CaCl2 treated mice, FR (fully recovered). Gating strategy is presented in figure S3 . Figure S2. Gating strategy of CD28-negative, and Tem/Tef and Tcm CD4 and CD8 T cells. Splenocytes wre stained with CD28-PE/ CD62L-APC/CD44-FITC in combination with CD4-PerCP or CD8-PerCP and analyzed by BD FACSCalibur and CellQuest software.
. Flow cytometric analysis of CTLA expression on CD4 and CD8 T cells in spleen. Tumor free mice, CRTL (untreated and only CaCl2 treated mice), PEF -PEF2 treated mice, PEF+Ca-PEF2 and CaCl2 treated mice, FR (fully recovered). Gating strategy is presented in figure S3 . Tef/Tem -T effector memory cells, Tcm -T central memory cells. Significant differences (p<0.05) between the mice groups according to Mann Whitney test are in bold, where red -significant versus CTRL wt; blue -significant versus CTRL. CTRL wt -untreated mice without tumors; CTRL -tumor bearing control mice without treatment; CTRL+Ca -tumor bearing mice treated with CaCl2; PEF1 and PEF2 -tumor bearing mice treated with PEF2 protocol -12 kV/cm × 500 ns × 500. PEF2+Catumor-bearing mice treated with PEF2 and CaCl2.
